Orchid is the first Indian company to be approved for this non-antibiotic product – Granisetron Hydrochloride Tablets
Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Granisetron Hydrochloride Tablets. The product is available in 1 mg dosage strength.
An anti-emetic product, Granisetron is a new generation non-antibiotic product and is effective against vomiting and nausea. They are typically used to treat motion sickness and the side effects of certain types of analgesics, general anaesthetics and chemotherapy directed against cancer. Orchid hopes to garner a strong market share leading to a sizeable revenue contribution from this product.